Covishield side-effects: India To Review COVID-19 Vaccine Af
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The central government decided to conduct a deeper review of post-vaccination side-effects from the Oxford-AstraZeneca coronavirus vaccine. The news came after several countries had suspended the rollout of AstraZeneca shot over blood clot fears. However, no cases of blood clots have been reported so far in the country.

Denmark, Norway, and Iceland paused the use of Oxford-AstraZeneca coronavirus vaccine as a precaution after isolated reports of recipients developing blood clots. The local version of Oxford-AstraZeneca COVID-19 vaccine is known as Covishield. Serum Institute of India, the world's largest vaccine manufacturer by volume, joined hands with AstraZeneca to produce 1 billion doses of its COVID-19 vaccine.

"We are looking at all the adverse events, particularly serious adverse events like deaths and hospitalization. We will come back if we find anything of concern," N.K. Arora, a member of India's national task force on COVID-19 told. Arora said there was "no immediate issue of concern as a number of adverse events is very, very low. We are relooking at to see if there was any issue of blood clotting."

"As of yesterday there were 59 or 60 deaths, and they were all coincidental," the doctor said. "In fact there is a real effort from our side that once the complete investigation is done, to put its results in the public domain, on the ministry of health website," Arora added.

India earlier granted emergency use approval to Covishield by Serum Institute of India and Covaxin by Bharat Biotech.A total of 16,39,663 beneficiaries that included health care workers (HCW) and front line workers (FLW) were vaccinated the first dose and 4,13,874 people received the second dose of the vaccine. So far, a cumulative total of 2,82,18,457 doses of the vaccine have been administered.

Source:
https://www.livemint.com/science/health/covishield-india-to-review-covid-19-vaccine-side-effects-after-concerns-in-europe-11615627257358.html
S●●●i J●●●i and 1 others like this1 share
Like
Comment
Share